- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Mekinist, as a MEK inhibitor, commonly has side effects including skin reactions, cardiac toxicity, and eye problems, which need to be alleviat...
Mekinist, as a MEK1/2 inhibitor, is mainly used for the treatment of BRAFV600 mutation positive tumors. Its indications include melanoma and no...
The contraindications of Mekinist involve specific populations, dietary restrictions, and medication conditions, and must be strictly followed ...
Acetazolamide tablets were initially approved for the treatment of glaucoma by selectively inhibiting carbonic anhydrase, reducing aqueous humo...
Alectinib is a targeted therapy for ALK positive non-small cell lung cancer. Its common side effects include liver dysfunction, muscle pain, an...
Alectinib is a second-generation ALK inhibitor mainly used for the treatment of ALK positive non-small cell lung cancer, with significant effic...
Alectinib, as a targeted drug for ALK positive non-small cell lung cancer, is contraindicated for individuals with severe liver function impair...
Alectinib, as a targeted drug for ALK positive non-small cell lung cancer, should be adjusted according to individual patient conditions in ter...
Ambrisentan is an endothelin receptor antagonist primarily used for the treatment of pulmonary arterial hypertension. Its common side effects i...
Ambrisentan is a selective endothelin receptor antagonist mainly used for the treatment of pulmonary arterial hypertension, and special attenti...
